CHA News Article

Effective Date of Final Rule on 340B Drug Ceiling Prices Delayed
Interim final rule sets new date of May 22

The Health Resources and Services Administration (HRSA) has again delayed the effective date of its final rule on drug ceiling prices and civil monetary penalties for manufacturers in the 340B Drug Pricing Program. Earlier this month, HRSA announced a two-week delay of the date, setting it at March 21. Last week, it issued a new interim final rule further postponing the effective date to May 22.

HRSA stated it believes the delay is necessary to allow consideration of questions raised about policies set forth in the rule, as well as to give providers time to implement its requirements. Additionally, the agency requests comments, due by April 17, on whether a longer delay of the effective date to Oct. 1 would be more appropriate.